Controlling glycolysis to generate characteristic volatile organic compounds of lung cancer cells

Characteristic volatile organic compounds (VOCs) are anticipated to be used for the identification of lung Cancer cells. However, to date, consistent biomarkers of VOCs in lung Cancer cells have not been obtained through direct comparison between Cancer and healthy groups. In this study, we regulated the glycolysis, a common metabolic process in Cancer cells, and employed solid phase microextraction gas chromatography mass spectrometry (SPME-GC-MS) combined with untargeted analysis to identify the characteristic VOCs shared by Cancer cells. The VOCs released by three types of lung Cancer cells (A549, PC-9, NCI-H460) and one normal lung epithelial cell (BEAS-2B) were detected using SPME-GC-MS, both in their resting state and after treatment with glycolysis inhibitors (2-Deoxy-D-glucose, 2-DG/3-Bromopyruvic acid, 3-BrPA). Untargeted analysis methods were employed to compare the VOC profiles between each type of Cancer cell and normal cells before and after glycolysis regulation. Our findings revealed that compared to normal cells, the three types of lung Cancer cells exhibited three common differential VOCs in their resting state: ethyl propionate, acetoin, and 3-decen-5-one. Furthermore, under glycolysis control, a single common differential VOC-acetoin was identified. Notably, acetoin levels increased by 2.60-3.29-fold in all three lung Cancer cell lines upon the application of glycolysis inhibitors while remaining relatively stable in normal cells. To further elucidate the formation mechanism of acetoin, we investigated its production by blocking glutaminolysis. This interdisciplinary approach combining metabolic biochemistry with MS analysis through interventional synthetic VOCs holds great potential for revolutionizing the identification of lung Cancer cells and paving the way for novel cytological examination techniques.

Cytological examination; Glycolysis regulation; Lung cancer; SPME–GC–MS; VOCs.